Progress of pathological classification in evaluating the prognosis of diffuse large B-cell lymphoma
10.3760/cma.j.cn115356-20220920-00264
- VernacularTitle:病理分型在弥漫大B细胞淋巴瘤预后评估中的研究进展
- Author:
He LIU
1
;
Huizheng BAO
Author Information
1. 长春中医药大学，长春 130117
- Keywords:
Lymphoma, large B-cell, diffuse;
Prognosis;
Molecular subtypes
- From:
Journal of Leukemia & Lymphoma
2023;32(12):763-765
- CountryChina
- Language:Chinese
-
Abstract:
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, with significant invasive and heterogeneous pathological morphology and clinical manifestations. In recent years, genomic analysis has yielded different molecular profile subsets, thus explaining the heterogeneity of DLBCL and enabling personalized precision therapy. This review summarizes the complex biology of DLBCL and discusses the potential impact of pathological classification on precision therapy of DLBCL.
